Achieve Life Sciences (ACHV) Cash from Restructuring (2010 - 2015)
Achieve Life Sciences (ACHV) recorded quarterly Cash from Restructuring of -$194000.0 in Q1 2015, up 27.34% on a QoQ basis from -$267000.0 in Q4 2014, and down 2.65% year-over-year from -$199271.7 in Q1 2014.
Achieve Life Sciences (ACHV) Cash from Restructuring (2010 - 2015) Analysis & Trends
Achieve Life Sciences has disclosed Cash from Restructuring across 5 years of filings, most recently posting -$194000.0 for Q1 2015.
- Quarterly Cash from Restructuring fell 2.65% year-over-year to -$194000.0 in Q1 2015, while the trailing twelve-month figure through Dec 2015 was -$194000.0 (up 77.15% YoY) and the FY2015 annual result came in at -$194000.0, up 75.29% from the prior year.
- Cash from Restructuring advanced to -$194000.0 in Q1 2015, from -$267000.0 in the prior quarter.
- Over five years, Cash from Restructuring peaked at -$164000.0 in Q1 2013 and troughed at -$1.7 million in Q4 2012.
- A 4-year average of -$338000.0 and a median of -$191500.0 in 2014 frame the typical range for Cash from Restructuring.
- Annual changes were most pronounced in 2013 — Cash from Restructuring surged 89.38% — and 2014, when it slumped 51.7%.
- Tracing ACHV's Cash from Restructuring over 4 years: stood at -$1.7 million in 2012, then jumped by 89.38% to -$176000.0 in 2013, then sank by 51.7% to -$267000.0 in 2014, then gained by 27.34% to -$194000.0 in 2015.
- Business Quant data shows ACHV's Cash from Restructuring at -$194000.0 in Q1 2015, -$267000.0 in Q4 2014, and -$199000.0 in Q3 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Achieve Life Sciences | 93.71 Mn | 63.22 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2015 | -194,000.00 |
| Dec 31, 2014 | -267,000.00 |
| Sep 30, 2014 | -199,000.00 |
| Jun 30, 2014 | -194,000.00 |
| Mar 31, 2014 | -189,000.00 |
| Dec 31, 2013 | -176,000.00 |
| Sep 30, 2013 | -173,000.00 |
| Jun 30, 2013 | -167,000.00 |
| Mar 31, 2013 | -164,000.00 |
| Dec 31, 2012 | -1.66 Mn |
| Sep 30, 2010 | 4.04 Mn |